Haptoglobin is an acute-phase protein, the primary role of which is to bind free haemoglobin, preventing iron loss and renal damage.' Haem removal limits iron-catalysed free radical generation, viral/bacterial growth and prostaglandin synthesis, so modulating the activity of the immune system. Additionally, haptoglobin itself can regulate angiogenesis and certain aspects of the immune system.?
Three major haptoglobin phenotypes are known: Hp 1-1, Hp 2-1 and Hp 2-2. 2 Hp I-I, as the smallest haptoglobin, has unrestricted access to tissues and binds haemoglobin more efficiently than Hp 2-2. Hp(l-I) individuals may therefore have an advantage over other phenotypes in certain disease states. Clinical studies have indeed shown that functional differences between phenotypes do playa role in a number of diseases. Hp(2-2) individuals are more likely to develop atherosclerosis, refractory hypertension and to show worse lipid profiles.i They have Correspondence: Julie Wassell. a poorer prognosis following liver transplantation' and infection with human immunodeficiency virus (HIV)4 or tuberculosis.? Knowledge of phenotype may therefore contribute to a better understanding of these disorders and allow treatments to be tailored to an individual's needs.
To date, phenotyping methods have involved electrophoresis of haemoglobin-supplemented serum using starch, acetate or polyacrylamide gels.
Haptoglobin-haemoglobin complex formation enhances the peroxidase activity of haemoglobin, allowing the phenotypic bands to be visualized using peroxidase-sensitive stains," These stains, however, are both toxic and carcinogenic. Less hazardous procedures using immunoblotting.l immunofixation" and isoelectric focusing? have also been developed, resulting in improvements in sensitivity, although the methods are lengthy, expensive and often complex.
We have developed a new phenotyping method that combines the use of agarose gel electrophoresis with a less toxic stain. The method is easier to use, safer and more suitable for use in the laboratory.
MATERIALS

Standards
Purified haptoglobin phenotype standards (Sigma Chemical Company, Dorset, UK) were dissolved in 1mL of double-distilled water (final concentration 1 g/L), aliquoted and stored at -30°C.
Free haemoglobin
Whole blood was washed twice with 0·9% (vjv) saline, then diluted with double-distilled water to approximately 10% haemoglobin (measured by a Coulter counter using the cyanomethaemoglobin method) after the final wash. This solution was stored at 4°C.
Electrophoresis
All electrophoresis was carried out using Titan Gel® acid haemoglobin kits (Helena Laboratories, Tyne and Wear, UK). The citratemaleate electrophoresis buffer (pH 6'2) was supplied with the kits.
Stain
All reagents were supplied by Sigma. The stain was prepared immediately before use. It contained 5mL of 0·2% (wjv) 3,3',5,5'-tetramethylbenzidine in methanol with O'5 mL of dimethylsulphoxide, IOmL of 5% (vjv) glacial acetic acid, 1mL of 1% (wjv) potassium ferricyanide and 150 J.lL of 30% (wjw) hydrogen peroxide.
FixativeJdestain A mixture of methanol-double-distilled waterglacial acetic acid (2:8:1, vjv) was used. All reagents were from BDH (Poole, UK).
METHODS
Electrophoresis
Free haemoglobin (5 J.lL) was added to 95 J.lL of serum samples from patients or haptoglobin standards. Samples were vortexed and allowed to stand for 5 min, during which time the haptoglobin-haemoglobin complex formed.
Aliquots (3 J.lL) of each sample were loaded onto the gel using a template, and electrophoretic separation was carried out for 35 min at 50 V and 20 rnA in a Titan Gel chamber as described in the manufacturer's instructions.
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At the end of each run, gels were fixed for 2 min prior to staining for 10min; destaining was by two 5-min washes in gel fixative. Gels were rinsed under tap water, dried in an oven at 65°C for 30 min and stored at room temperature in the absence of light to minimize fading. Sensitivity A representative sample was taken from patients of each phenotype and haptoglobin concentration determined using an immunoturbidimetric method with polyethylene glycol (PEG)enhanced precipitation (Dako Ltd, Buckinghamshire, UK). Samples were diluted in 0·9% (vjv) saline to give concentrations of 1'0, 0,8, 0'6, 0·4 and 0·2 gjL (±O'I g/L) prior to electrophoresis. The minimum haptoglobin concentration needed for reliable typing was determined by two independent observers.
Method validation
Representative samples of each phenotype (n = 10) were sent to an independent laboratory for phenotyping by starch gel electrophoresis. The results were compared double-blindly with those from our method. Additionally, our method was used to determine the phenotype of 125 samples from patients attending the outpatient department. The banding pattern observed was compared with that of commercially available haptoglobin standards and the phenotype distribution within this population compared with reported figures. Mean haptoglobin concentrations in each phenotype group were compared by one-way analysis of variance after logarithmic transformation of the data.
RESULTS
Haptoglobin phenotypes migrated at different speeds towards the cathode, allowing each to be readily recognized (Fig. 1) . The electrophoretic pattern showed Hp 1-1 as a single, fast, cathodally migrating band and Hp 2-2 as a series of slower, less densely stained bands; the heterozygote Hp 2-1 showed features of both patterns (Fig. 1) .
By our method, phenotypes showed 100% agreement with starch gel electrophoresis. Additionally, our method readily distinguished between haptoglobin phenotypes in both commercial standards and serum samples from patients (n = 125) with haptoglobin concentrations above or equal to 0·4 g/L, In our study, only five patients had a haptoglobin concentration below this limit of detection. The phenotype distribution in our population was: HP(I-I). 19%; HP(2-1), 45%; and HP(2-2). 36%. Haptoglobin concentration varied with phenotype. with the HP(2-2) group showing significantly lower concentrations than the other phenotypes (n = 125. P < 0·000I) (Fig. 2) . During the optimization of this technique, no observable differences were found when samples were incubated with haemoglobin for 5. 10 or 20min prior to electrophoresis. Additionally, fixing the gels for just 2 min but destaining for two sets of 5 min in gel fixative produced maximum band intensity and kept the degree of fading during drying to a minimum. Gels were stable for up to 2 months when stored in the absence of light.
DISCUSSION
Our method agreed with the results for phenotypes determined independently by starch gel electrophoresis, and the banding pattern we observed was similar to that found by others.s" The phenotype distribution within our mainly Caucasian population compared well with that reported in the literature. For northwestern Europe, approximately 16% of individuals are Hp(1-1), 48% Hp(2-1) and 36% Hp . 2 We also observed that the Hp(2-2) group had the lowest haptoglobin concentration of all phenotypes. This has been previously reported and lends further weight to the validity of our technique. Although the sensitivity of our method (0'4 g/L) was predictably less than the 0·2 g/L reported for immunologically based techniques," it was markedly greater than other methods using only electrophoresis and peroxidase-sensitive stains (1'2 g/L).6 In addition to sensitivity, our agarose gel method has additional advantages over previous gel types in that it is easy to use and the gels dry rapidly, give reproducible results and are commercially available.
To date, staining-based methods for haptoglobin phenotyping have used o-hydroxy aromatic amine derivatives.P'? These materials are both toxic and carcinogenic, making them generally unsuitable for use in the laboratory." The stain used in this study, 3,3'5,5'-tetramethlybenzidine, is significantly less toxic than these earlier materials? and is therefore safer to use.
In summary, our method can provide a safe alternative to the often time-consuming, complex and costly immunologically based methods for haptoglobin phenotyping. This may allow phenotyping to playa more prominent role in the biochemical assessment of cardiovascular disease, autoimmune disorders and infectious diseases. Knowledge of phenotype may allow improved patient management and better tailoring of treatments for these disorders to suit individuals' needs.
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